$96,578,166
to RIGHT TO CARE ZAMBIA LIMITED
THE PRIMARY PURPOSE OF USAID MECH IS TO REDUCE HIV MORTALITY, MORBIDITY AND TRANSMISSION BY ACHIEVING THE UNAIDS AND PEPFAR GOAL OF 95/95/95 HIV TREATMENT COVERAGE AND PROVIDING COMPREHENSIVE HIV PREVENTION AND CARE AND TREATMENT MAINTENANCE SERVICES
Verbatim from USAspending.gov. Capitalization, abbreviations, and codes are unchanged.
What the model surfaced from this award
Latest obligation on a 2021 USAID HIV treatment program in Zambia targeting 95/95/95 treatment coverage and comprehensive prevention services.
PEPFAR remains a cornerstone of U.S. global health diplomacy; this 2021–2028 mechanism sustains HIV mortality reduction in a high-burden country.
Supports pharmaceutical supply chains and clinical infrastructure in Zambia; depends on antiretroviral drug availability and health-system capacity.
U.S. health diplomacy in sub-Saharan Africa competes with Chinese infrastructure and aid initiatives for regional influence.
Generated by award_classification v2.1.0 via claude-haiku-4-5-20251001 on 2026-05-29. Cost: $0.003057.
- USAspending.gov — all awards for this UEI →
- SAM.gov entity registration →
- Award record ingested from usaspending. Source identifier CONT_AWD_72061121C00006_7200_-NONE-_-NONE-.
The Buildout does not edit federal records. Any inaccuracy reflects the upstream source; it will update here when corrected there.